School of Medicine
Showing 31-40 of 42 Results
-
Aditya Srivatsan
Affiliate, Department Funds
Resident in Neurology & Neurological SciencesBioStanford Neurology Physician Resident, PGY-3
-
Kristen K. Steenerson, MD
Clinical Associate Professor, Otolaryngology (Head and Neck Surgery)
Clinical Assistant Professor, Adult NeurologyBioKristen K. Steenerson, MD is a board-certified neurologist with fellowship training in vestibular neurology. She graduated cum laude from Claremont McKenna College, received her MD from the University of Utah, completed neurology residency at Mayo Clinic Arizona, and fellowship at Barrow Neurological Insitute. She directs the Vestibular Balance Disorders Program of the Stanford Balance Center. She has joint appointments in the departments of Otolaryngology--Head and Neck Surgery and Neurology & Neurological Sciences at Stanford. Her clinical interests include vestibular migraine, benign paroxysmal positional vertigo, Ménière's disease, and international neurology.
-
Gary K. Steinberg, MD, PhD
Bernard and Ronni Lacroute-William Randolph Hearst Professor of Neurosurgery and Neurosciences and Professor, by courtesy, of Neurology and Neurological Sciences
Current Research and Scholarly InterestsOur laboratory investigates the pathophysiology and treatment of cerebral ischemia, and methods to restore neurologic function after stroke. Treatment strategies include brain hypothermia, stem cell transplantation and optogenetic stimulation. Our clinical research develops innovative surgical, endovascular and radiosurgical approaches for treating difficult intracranial aneurysms, complex vascular malformations and occlusive disease, including Moyamoya disease, as well as stem cell transplant.
-
Lawrence Steinman, MD
George A. Zimmermann Professor and Professor of Pediatrics
Current Research and Scholarly InterestsOur laboratory is dedicated to understanding the pathogenesis of autoimmune diseases, particularly multiple sclerosis. We have developed several new therapies for autoimmunity, including some in Phase 2 clinical trials, as well as one approved drug, natalizumab. We have developed microarray technology for detecting autoantibodies to myelin proteins and lipids. We employ a diverse range of molecular and celluar approaches to trying to understand multiple sclerosis.
-
Minhui Su
Postdoctoral Scholar, Neurology and Neurological Sciences
BioMinhui Su, PhD is a postdoctoral fellow at the Neurology Department. She is investigating neuronal activity-regulated glioma growth, specifically how membrane depolarization regulates glioma growth in the tumor microenvironment.
She obtained her PhD in Molecular Biology, with a focus on neuroimmunology, at the International Max Planck Research School (IMPRS) at Georg August University Göttingen, Germany. Her PhD research discovered that inflammation is an essential early step of myelin regeneration, and uncovered the roles of microglia (the resident immune cells of the central nervous system) in myelin damage response.
She enjoys science, art and hiking in her free time.
